P. Altmann

发表

Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: retrospective study of the Camelford water incident

P. Altmann, J. Cunningham, U. Dhanesha, 1999, BMJ.

A user-centred home monitoring and self-management system for patients with heart failure: a multicentre cohort study.

Carmelo Velardo, Lionel Tarassenko, Andreas Triantafyllidis, 2015, European heart journal. Quality of care & clinical outcomes.

Assessment of hypoproteinaemic oedema: a simple physical sign.

P. Altmann, J. Henry, 1978, British medical journal.

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.

M. Landray, R. Collins, D. Wheeler, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Aluminium toxicity in dialysis patients: no evidence for a threshold serum aluminium concentration.

P. Altmann, 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis.

P. Altmann, C. Rose, N. Zalunardo, 2007, Kidney international.

Validity of simplified protocols to estimate glomerular filtration rate using iohexol clearance

J. Levy, P. Altmann, T. James, 2007, Annals of clinical biochemistry.

Chapter 1 – Aluminium Induced Disease in Subjects with and without Renal Failure—Does It Help Us Understand the Role of Aluminium in Alzheimer’s Disease?

P. Altmann, 2001 .

DISTURBANCE OF CEREBRAL FUNCTION BY ALUMINIUM IN HAEMODIALYSIS PATIENTS WITHOUT OVERT ALUMINIUM TOXICITY

P. Altmann, J. Cunningham, U. Dhanesha, 1989, The Lancet.

Serum aluminum levels and erythrocyte dihydropteridine reductase activity in patients on hemodialysis.

P. Cutler, P. Altmann, J. Cunningham, 1987, The New England journal of medicine.

Camelford water incident aluminium sulphate: retrospective study of the exposed to drinking water contaminated with Disturbance of cerebral function in people

P. Altmann, J. Cunningham, U. Dhanesha, 2006 .

Sevelamer

P. Altmann, J. Henderson, 2003, Nephron Clinical Practice.

Silicone-induced hypercalcaemia in haemodialysis patients.

A. Williams, P. Altmann, J. Cunningham, 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

High serum D-lactate in patients on continuous ambulatory peritoneal dialysis.

G. Radda, K. Clarke, P. Altmann, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The management of severe hypercalcaemia.

P. Altmann, J. Cunningham, 1987, Postgraduate medical journal.

Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain

P. Altmann, V. Prasher, J. Blair, 1990, The Lancet.

Authors' reply to Camelford letters

John Cunningham, James Thompson, Paul Altmann, 2000, BMJ : British Medical Journal.

Penile calciphylaxis: an unusual cause of penile necrosis

P. Altmann, I. Roberts, I. Prematilleke, 2012, Histopathology.

Black urine.

P. Altmann, M. Mansell, 1980, Postgraduate medical journal.

ALUMINIUM CHELATION THERAPY IN DIALYSIS PATIENTS: EVIDENCE FOR INHIBITION OF HAEMOGLOBIN SYNTHESIS BY LOW LEVELS OF ALUMINIUM

P. Altmann, J. Cunningham, F. Marsh, 1988, The Lancet.

The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD.

M. Landray, R. Collins, D. Adu, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Giant lichenification of the scalp

P. Altmann, F. Wojnarowska, G. Arseculeratne, 2003, Clinical and experimental dermatology.

Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance.

J. Levy, P. Altmann, T. James, 2002, Diabetes care.

Gallium (aluminium) transferrin binding in Alzheimer's disease

P. Hodgkins, P. Altmann, G. Farrar, 1992, The Lancet.

High-dose calcium carbonate with stepwise reduction in dialysate calcium concentration: effective phosphate control and aluminium avoidance in haemodialysis patients.

P. Altmann, J. Cunningham, F. Marsh, 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of direction and rate of change of calcium on parathyroid hormone secretion in uraemia.

P. Altmann, J. Cunningham, F. Marsh, 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Long-Term Effect of Low Calcium Dialysate on Parathyroid Activity in Dialysis Patients Treated with Calcium Carbonate as a Phosphate Binder

P. Altmann, J. Cunningham, F. Marsh, 1989 .

Residual renal function in hemodialysis patients may protect against hyperaluminemia.

P. Altmann, J. Cunningham, F. Marsh, 1987, Kidney international.

Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients

Payam Mohaghegh, P. Altmann, Melissa S. Murphy, 2015, Transfusion.

Long-term bone densitometry post-renal transplantation in patients treated with either cyclosporin or prednisolone.

P. Altmann, R. Parry, J. Stevens, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.

M. Yaqoob, M. Hall-Craggs, P. Altmann, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cognitive function in Stage 5 chronic kidney disease patients on hemodialysis: no adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy.

P. Altmann, W. Finn, M. E. Barnett, 2007, Kidney international.

Silicon and aluminium interactions in haemodialysis patients.

A. Davenport, P. Altmann, J. Birchall, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Viriligo and Motor Neurone Disease Following Acute Polymyalgia Rheumatica

P. Altmann, A. Crisp, P. Ranger, 1981, The British journal of clinical practice.

EBV-genome positive monoclonal B cell cerebral lymphoma in a renal allograft recipient following OKT3 therapy.

M. Raftery, P. Altmann, J. Cunningham, 1992, Nephrology, Dialysis and Transplantation.

Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: retrospective study of the Camelford water incident

P. Altmann, J. Cunningham, U. Dhanesha, 1999, BMJ.